Redirecting to https://pharma.economictimes.indiatimes.com/news/regulatory-update/mercks-ifinatamab-deruxtecan-receives-fast-track-approval-for-lung-cancer-treatment/123383564?utm_source=latest_news&utm_medium=homepage